3543 results for «2154»

Filter By

3543 results

How to address the problem of calcified left main lesions

22 May 2025 – From EuroPCR 2025

Gain expert perspectives on addressing calcified left main coronary lesions in high-risk and complex clinical scenarios. This session features challenging cases including ACS patients with reduced LVEF, severe calcified stenosis of left main bifurcation, complex PCI in post-CABG octogenarians with rotablation under Impella support, and other...

How to address the problem of calcified left main lesions

Management of challenging TAVI device delivery

22 May 2025 – From EuroPCR 2025

Explore innovative solutions for managing challenging TAVI device delivery. This session presents cases involving kinked and stuck Navitor valves, the use of snare devices for retrieval, balloon-expandable TAVI in severe bicuspid aortic stenosis, and alternative access routes such as transaortic access after failed transfemoral valve-in-valve procedures.

Management of challenging TAVI device delivery

A central role for cardiac imaging in transcatheter LAA closure

22 May 2025 – From EuroPCR 2025

Discover the central role of cardiac imaging in transcatheter left atrial appendage (LAA) closure. This session covers sealing techniques, advances in cardiac tomography for assessing LAA wall thickness, fusion of 3D computational modeling with fluoroscopy guidance, device healing evaluation through early serial imaging, and complex cases...

A central role for cardiac imaging in transcatheter LAA closure

Optimal acute heart failure care: must have, must do

22 May 2025 – From EuroPCR 2025

This session presents must-have strategies for optimal acute heart failure care. Topics include establishing an extracorporeal cardiopulmonary resuscitation referral center with patient outcomes, percutaneous closure in ventricular septal rupture, modified manual compression for large-bore sheaths, antithrombotic therapy considerations in AMI complicated by cardiogenic shock with mechanical...

Optimal acute heart failure care: must have, must do

Optimal SCAD treatment

22 May 2025 – From EuroPCR 2025

Navigate the complexities of spontaneous coronary artery dissection (SCAD) treatment through clinical case discussions. This session explores identifying the culprit lesion, recurrent ACS challenges, the conservative versus PCI treatment dilemma, and real-world presentation scenarios emphasizing decision-making in SCAD management.

Optimal SCAD treatment

PCI in a challenging coronary anatomy

22 May 2025 – From EuroPCR 2025

This session tackles PCI in challenging coronary anatomies, featuring cases with anomalous coronary arteries, complex access routes, and specialized stenting techniques. Learn from experiences managing dual anomalous arteries, navigating to difficult lesions, and applying innovative modified chimney stent methods to restore coronary flow.

PCI in a challenging coronary anatomy

Combined LAA closure and transcatheter mitral valve repair - LIVE Case

22 May 2025 – From EuroPCR 2025

An 82-year-old male patient with a history of PM (pacemaker) implantation in 2024, and ischaemic cardiomyopathy presented with symptomatic heart failure due to severe secondary mitral regurgitation and impaired LV function (EF 40 %). He also presented with recurrent gastro-intestinal bleeding while on DOAC for atrial...

Combined LAA closure and transcatheter mitral valve repair - LIVE Case

Redo TAVI - How to treat different TAVI platforms when they fail

22 May 2025 – From EuroPCR 2025

Understand the complexities of redo TAVI procedures with emphasis on planning, valve platform characteristics, and tailored procedural strategies. This session features cases of redo TAVI for failed short-frame and tall-frame valves, alongside discussions on current evidence gaps guiding optimal management.

Redo TAVI - How to treat different TAVI platforms when they fail

TAVI coronary access

22 May 2025 – From EuroPCR 2025

Gain expertise in managing coronary access challenges in TAVI patients. This session discusses when and how to treat coronary lesions in TAVI candidates, strategies to facilitate coronary approach post-TAVI, and long-term outcomes with practical tips through illustrative cases including primary PCI after CoreValve implantation and valve-in-valve...

TAVI coronary access

High thrombus burden in STEMI

22 May 2025 – From EuroPCR 2025

This session addresses the management of high thrombus burden in STEMI patients. It reviews available tools and strategies for thrombus management, presents multiple case-based discussions illustrating treatment decisions, and explores the evolving role of thrombus aspiration in contemporary practice.

High thrombus burden in STEMI

When angina cannot be cured with stents: what are the remaining options

22 May 2025 – From EuroPCR 2025

Explore therapeutic options for patients with angina refractory to stenting. This session reviews the efficacy and clinical outcomes of coronary sinus (CS) reducer implantation for microvascular dysfunction, factors influencing procedural success, next-generation CS reducer innovations, and the role of aspirin in angina without obstructive coronary disease.

When angina cannot be cured with stents: what are the remaining options

Beyond the intervention: outcomes of CTO PCI

22 May 2025 – From EuroPCR 2025

Discover long-term outcomes and practical insights into chronic total occlusion (CTO) PCI. This session presents real-world registry data, cost-effectiveness analyses, effects of successful revascularisation in reduced ejection fraction and heart failure patients, and specific outcomes in octogenarian populations.

Beyond the intervention: outcomes of CTO PCI

Artificial intelligence in the cathlab

22 May 2025 – From EuroPCR 2025

Delve into the transformative role of artificial intelligence (AI) in the cathlab. This session covers AI applications for vulnerable plaque identification using intracoronary OCT, automated coronary angiogram analysis, rapid AI-based OCT interpretation, AI-enhanced decision-making for PCI optimization, and noninvasive microvascular resistance assessment powered by AI.

Artificial intelligence in the cathlab

PCI for complex calcific coronary artery disease - LIVE Case

22 May 2025 – From EuroPCR 2025

An 87-year-old female patient, at high bleeding risk and with preserved LV function, presented 2 months ago with an inferior STEMI and multivessel disease. She initially underwent RCA PCI followed by staged LCx PCI. She was now referred for PCI of a long, heavily calcified lesion...

PCI for complex calcific coronary artery disease - LIVE Case

Antiplatelet strategies for patients undergoing PCI

22 May 2025 – From EuroPCR 2025

Delve into this comprehensive session focusing on antiplatelet strategies for patients undergoing PCI. Explore evidence and clinical insights on ticagrelor monotherapy post-AMI stenting, shortened dual antiplatelet therapy (DAPT) durations, the role of CYP2C19 genotyping in stent thrombosis risk, the effectiveness of dual antithrombotic therapy in atrial...

Antiplatelet strategies for patients undergoing PCI

TAVI in bicuspid: all you need to know

22 May 2025 – From EuroPCR 2025

Understand the unique anatomical and clinical challenges of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valves. This session covers bicuspid valve epidemiology, indications for surgery and TAVI, and detailed discussion on sizing and deployment fundamentals specific to bicuspid anatomy to optimize procedural success.

TAVI in bicuspid: all you need to know

Radiation protection: the good and the bad

22 May 2025 – From EuroPCR 2025

This session provides essential guidance on radiation protection in the cath lab. Learn practical steps to minimize radiation exposure for yourself and your team, manage the ergonomic challenges of protective gear, and develop skills to foster a culture of radiation safety within your workplace. Understand the...

Radiation protection: the good and the bad

Managing ischaemic and bleeding risk of NSTEMI patients

22 May 2025 – From EuroPCR 2025

Gain valuable insights into managing ischemic and bleeding risks in NSTEMI patients. This session reviews optimal timing for invasive strategies, variability in care processes, radial access approaches, and innovative antithrombotic strategies such as aspirin omission and prasugrel monotherapy to minimize bleeding while optimizing outcomes.

Managing ischaemic and bleeding risk of NSTEMI patients

Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism; where do we stand?

22 May 2025 – From EuroPCR 2025

Explore the evolving landscape of catheter-directed therapy for intermediate-high and high-risk pulmonary embolism. This session covers patient selection criteria, clinical signs indicating the need for intervention, management of potential complications, and ongoing studies shaping future treatments. Case-based discussions illustrate practical applications and key learnings.

Catheter-directed therapy for intermediate-high-risk and high-risk pulmonary embolism; where do we stand?

Challenges and risks of percutaneous treatment of calcified lesions

22 May 2025 – From EuroPCR 2025

Learn how to effectively manage calcified coronary lesions and their associated risks in this focused session. Understand the critical role of plaque modification and intravascular imaging, and gain insights into addressing stent thrombosis following interventions on calcified lesions through detailed case analyses.

Challenges and risks of percutaneous treatment of calcified lesions
Didn’t find what you were looking for?